Apyx Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	31.14	31.74	31.74	43.65	10.19	30.87
Cash & Short-Term Investments	31.14	31.74	31.74	43.65	10.19	30.87
Cash Growth	0.41%	-0.00%	-27.29%	328.30%	-66.98%	-26.35%
Accounts Receivable	12.76	16.78	15.48	14.02	10.6	13.04
Other Receivables	-	-	-	-	7.64	8.13
Total Trade Receivables	12.76	16.78	15.48	14.02	18.25	21.16
Inventory	9.54	8.6	7.56	9.92	11.8	6.78
Other Current Assets	1.37	1.35	1.66	2.76	2.74	1.93
Total Current Assets	54.8	58.47	56.44	70.36	42.97	60.74
Net Property, Plant & Equipment	6.35	6.62	6.74	7.15	7.59	6.87
Other Long-Term Assets	1.88	1.75	1.66	1.73	1.22	1.11
Total Assets	63.03	66.84	64.84	79.24	51.78	68.72
Accounts Payable	2.63	3.06	2.62	2.71	2.67	2.63
Accrued Expenses	6.38	8.21	7.75	9.66	8.93	10.29
Current Portion of Leases	0.44	0.43	0.36	0.37	0.25	0.29
Total Current Liabilities	9.45	11.7	10.72	12.74	11.85	13.21
Long-Term Debt	35.09	34.85	33.89	33.19	-	-
Long-Term Leases	3.93	4.06	4.52	4.95	0.54	0.02
Other Long-Term Liabilities	1.47	1.4	1.38	1.44	1.59	1.49
Total Long-Term Liabilities	40.49	40.31	39.79	39.58	2.13	1.51
Total Liabilities	49.94	52.01	50.51	52.32	13.98	14.71
Common Stock	0.04	0.04	0.04	0.04	0.04	0.03
Additional Paid-in Capital	104.02	103.62	92.08	81.11	73.28	66.22
Retained Earnings	-91.23	-89.12	-77.91	-54.45	-35.74	-12.55
Total Common Shareholders' Equity	12.83	14.54	14.21	26.7	37.58	53.7
Minority Interest	0.26	0.29	0.13	0.22	0.21	0.31
Shareholders' Equity	13.09	14.83	14.34	26.92	37.79	54.01
Total Liabilities & Equity	63.03	66.84	64.84	79.24	51.78	68.72
Total Debt	39.46	39.34	38.76	38.5	0.8	0.31
Net Cash (Debt)	-8.32	-7.6	-7.02	5.15	9.4	30.57
Net Cash Growth	-	-	-	-45.18%	-69.26%	-25.88%
Net Cash Per Share	-0.20	-0.18	-0.20	0.15	0.27	0.89
Book Value	12.83	14.54	14.21	26.7	37.58	53.7
Book Value Per Share	0.31	0.35	0.40	0.77	1.09	1.56
Tangible Book Value	12.83	14.54	14.21	26.7	37.58	53.7
Tangible Book Value Per Share	0.31	0.35	0.40	0.77	1.09	1.56

SEC Filings: 10-K · 10-Q